For patients with early stage breast cancer standard of care is breast conserving-surgery (BCS) followed by adjuvant radiotherapy and adjuvant systemic therapy according to the estrogen (ER) and progesterone receptor (PR) as well as human epidermal growth factor receptor 2 (HER2) status [1]. Here, PGR is linked to breast cancer.